XML 153 R27.htm IDEA: XBRL DOCUMENT v3.19.3
UNAUDITED QUARTERLY DATA
12 Months Ended
Jun. 30, 2019
Quarterly Financial Information Disclosure [Abstract]  
UNAUDITED QUARTERLY DATA
NAUDITED QUARTERLY DATA
 
 
Three months ended
($ in thousands, except per share data)
 
September 30, 2018
 
December 31, 2018
 
March 31, 2019
 
June 30, 2019
 
 
(unaudited)
 
(unaudited)
 
(unaudited)
 
(unaudited)
 
 
 
 
 
 
 
 
 
Revenue
 
$
33,522

 
$
34,406

 
$
37,646

 
$
38,225

Gross profit
 
$
10,110

 
$
9,243

 
$
9,779

 
$
8,987

Operating loss
 
$
(5,921
)
 
$
(10,200
)
 
$
(3,892
)
 
$
(10,143
)
Net loss
 
$
(6,320
)
 
$
(10,657
)
 
$
(4,510
)
 
$
(10,541
)
Cumulative preferred dividends
 
$
(334
)
 
$

 
$
(334
)
 
$

Net loss applicable to common shares
 
$
(6,654
)
 
$
(10,657
)
 
$
(4,844
)
 
$
(10,541
)
Net loss per common share - basic
 
$
(0.11
)
 
$
(0.18
)
 
$
(0.08
)
 
$
(0.18
)
Net loss per common share - diluted
 
$
(0.11
)
 
$
(0.18
)
 
$
(0.08
)
 
$
(0.18
)
Weighted average number of common shares outstanding - basic
 
60,053,912

 
60,059,936

 
60,065,053

 
60,065,978

Weighted average number of common shares outstanding - diluted
 
60,053,912

 
60,059,936

 
60,065,053

 
60,065,978

 
 
Three months ended
($ in thousands, except per share data)
 
September 30, 2017
(As Restated)
 
December 31, 2017
(As Restated)
 
March 31, 2018
(As Restated)
 
June 30, 2018
 
 
(unaudited)
 
(unaudited)
 
(unaudited)
 
(unaudited)
Revenue
 
$
25,259

 
$
31,532

 
$
33,592

 
$
42,125

Gross profit
 
$
6,181

 
$
9,172

 
$
9,845

 
$
10,478

Operating loss
 
$
(1,750
)
 
$
(3,905
)
 
$
(2,566
)
 
$
(1,002
)
Net loss
 
$
(2,171
)
 
$
(4,194
)
 
$
(3,223
)
 
$
(1,696
)
Cumulative preferred dividends
 
$
(334
)
 
$

 
$
(334
)
 
$

Net loss applicable to common shares
 
$
(2,505
)
 
$
(4,194
)
 
$
(3,557
)
 
$
(1,696
)
Net loss per common share - basic
 
$
(0.05
)
 
$
(0.08
)
 
$
(0.07
)
 
$
(0.03
)
Net loss per common share - diluted
 
$
(0.05
)
 
$
(0.08
)
 
$
(0.07
)
 
$
(0.03
)
Weighted average number of common shares outstanding - basic
 
47,573,364

 
52,150,106

 
53,637,085

 
54,064,750

Weighted average number of common shares outstanding - diluted
 
47,573,364

 
52,150,106

 
53,637,085

 
54,064,750


 
 
Three months ended
($ in thousands, except per share data)
 
September 30, 2016
(As Restated)
 
December 31, 2016
(As Restated)
 
March 31, 2017
(As Restated)
 
June 30, 2017
(As Restated)
 
 
(unaudited)
 
(unaudited)
 
(unaudited)
 
(unaudited)
 
 
 
 
 
 
 
 
 
Revenue
 
$
21,569

 
$
21,787

 
$
26,301

 
$
31,779

Gross profit
 
$
6,297

 
$
6,445

 
$
6,342

 
$
5,977

Operating loss
 
$
(1,383
)
 
$
109

 
$
(459
)
 
$
(2,401
)
Net loss
 
$
(3,370
)
 
$
(232
)
 
$
(925
)
 
$
(2,938
)
Cumulative preferred dividends
 
$
(334
)
 
$

 
$
(334
)
 
$

Net loss applicable to common shares
 
$
(3,704
)
 
$
(232
)
 
$
(1,259
)
 
$
(2,938
)
Net loss per common share - basic
 
$
(0.10
)
 
$
(0.01
)
 
$
(0.03
)
 
$
(0.07
)
Net loss per common share - diluted
 
$
(0.10
)
 
$
(0.01
)
 
$
(0.03
)
 
$
(0.07
)
Weighted average number of common shares outstanding - basic
 
38,488,005

 
40,308,934

 
40,327,697

 
40,331,993

Weighted average number of common shares outstanding - diluted
 
38,488,005

 
40,308,934

 
40,327,697

 
40,331,993


Explanatory Note:
The Company is providing restated quarterly and year-to-date unaudited consolidated financial information for interim periods occurring within fiscal years ended June 30, 2017 and 2018 in order to comply with SEC requirements. Refer to Note 2"Restatement of Consolidated Financial Statements" for further background concerning the events preceding the restatement of financial information in this Form 10-K.
As discussed in Note 2, the Audit Committee and the Company identified certain errors that are corrected through adjustments made as part of the restatement. These adjustments include corrections related to the investigation of customer transactions that was conducted, as well as (i) corrections related to the Company's acquisition and financial integration of Cantaloupe and (ii) corrections resulting from management's review of significant accounts and transactions.
A summary of the impact of these matters on income (loss) before taxes is presented below:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
Three months ended September 30, 2017
 
Three months ended December 31, 2017
 
Six months ended December 31, 2017
 
Three months ended March 31, 2018
 
Nine months ended March 31, 2018
Audit Committee Investigation-related Adjustments:
 
 
 
 
 
 
 
 
 
Revenue
$
(411
)
 
$
(866
)
 
$
(1,277
)
 
$
(768
)
 
$
(2,045
)
Costs of sales
$
165

 
$
(1,225
)
 
$
(1,060
)
 
$
(293
)
 
$
(1,353
)
Gross profit
$
(576
)
 
$
359

 
$
(217
)
 
$
(475
)
 
$
(692
)
Operating income (loss)
$
(576
)
 
$
359

 
$
(217
)
 
$
(9
)
 
$
(226
)
Income (loss) before income taxes
$
(576
)
 
$
357

 
$
(219
)
 
$
(29
)
 
$
(248
)
 
 
 
 
 
 
 
 
 
 
Acquisition and Financial Integration-related Adjustments:
 
 
 
 
 
 
 
 
 
Revenue
$

 
$
(60
)
 
$
(60
)
 
$
(1,546
)
 
$
(1,606
)
Costs of sales
$

 
$
(33
)
 
$
(33
)
 
$
(79
)
 
$
(112
)
Gross profit
$

 
$
(27
)
 
$
(27
)
 
$
(1,467
)
 
$
(1,494
)
Operating income (loss)
$

 
$
(288
)
 
$
(288
)
 
$
(1,594
)
 
$
(1,882
)
Income (loss) before income taxes
$

 
$
(223
)
 
$
(223
)
 
$
(1,499
)
 
$
(1,722
)
 
 
 
 
 
 
 
 
 
 
Significant Account and Transaction Review and Other:
 
 
 
 
 
 
 
 
 
Revenue
$
53

 
$
(47
)
 
$
6

 
$
75

 
$
81

Costs of sales
$
497

 
$
313

 
$
810

 
$
231

 
$
1,041

Gross profit
$
(444
)
 
$
(360
)
 
$
(804
)
 
$
(156
)
 
$
(960
)
Operating income (loss)
$
(622
)
 
$
(775
)
 
$
(1,397
)
 
$
(461
)
 
$
(1,858
)
Income (loss) before income taxes
$
(886
)
 
$
(1,041
)
 
$
(1,927
)
 
$
(696
)
 
$
(2,623
)
($ in thousands)
Increase / (Decrease) Restatement Impact
 
 
 
Three months ended September 30, 2016
 
Three months ended December 31, 2016
 
Six months ended December 31, 2016
 
Three months ended March 31, 2017
 
Nine months ended March 31, 2017
 
Three months ended June 30, 2017
Audit Committee Investigation-related Adjustments:
 
 
 
 
 
 
 
 
 
 
 
Revenue
$

 
$

 
$

 
$
(111
)
 
$
(111
)
 
$
(2,457
)
Costs of sales
$

 
$

 
$

 
$
(24
)
 
$
(24
)
 
$
(1,139
)
Gross profit
$

 
$

 
$

 
$
(87
)
 
$
(87
)
 
$
(1,318
)
Operating income (loss)
$

 
$

 
$

 
$
(87
)
 
$
(87
)
 
$
(1,318
)
Income (loss) before income taxes
$

 
$

 
$

 
$
(87
)
 
$
(87
)
 
$
(1,318
)
 
 
 
 
 
 
 
 
 
 
 
 
Significant Account and Transaction Review and Other:
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
(18
)
 
$
31

 
$
13

 
$
(49
)
 
$
(36
)
 
$
(53
)
Costs of sales
$
(148
)
 
$
(81
)
 
$
(229
)
 
$
147

 
$
(82
)
 
$
173

Gross profit
$
130

 
$
112

 
$
242

 
$
(196
)
 
$
46

 
$
(226
)
Operating income (loss)
$
(434
)
 
$
(124
)
 
$
(558
)
 
$
(790
)
 
$
(1,348
)
 
$
(1,516
)
Income (loss) before income taxes
$
(769
)
 
$
(441
)
 
$
(1,210
)
 
$
(1,159
)
 
$
(2,369
)
 
$
(1,831
)
A summary of the impact of these matters on the consolidated balance sheet is presented below, excluding any tax effect from the restatement adjustments in the aggregate:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
As of September 30, 2016
 
As of December 31, 2016
 
As of
March 31, 2017
 
As of September 30, 2017
 
As of December 31, 2017
 
As of
March 31, 2018
Audit Committee Investigation-related Adjustments:
 
 
 
 
 
 
 
 
 
 
 
Accounts receivables
$

 
$

 
$

 
$
(315
)
 
$
(1,774
)
 
$
(1,954
)
Finance receivables, net
$

 
$

 
$
92

 
$
(1,640
)
 
$
(1,269
)
 
$
(1,666
)
Inventory, net
$

 
$

 
$

 
$
941

 
$
2,166

 
$
2,459

Prepaid expenses and other current assets
$

 
$

 
$
30

 
$
25

 
$
25

 
$
25

Other assets
$

 
$

 
$
95

 
$
82

 
$
76

 
$
69

Property and equipment, net
$

 
$

 
$

 
$

 
$
(162
)
 
$
(146
)
Accounts payable
$

 
$

 
$
270

 
$
270

 
$
106

 
$
99

Accrued expenses
$

 
$

 
$
34

 
$
803

 
$
580

 
$
341

 
 
 
 
 
 
 
 
 
 
 
 
Acquisition and Financial Integration-related Adjustments:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$

 
$

 
$
(26
)
 
$
(52
)
Accounts receivables
$

 
$

 
$

 
$

 
$
1,133

 
$
(1,974
)
Finance receivables, net
$

 
$

 
$

 
$

 
$
(1,515
)
 
$
158

Inventory, net
$

 
$

 
$

 
$

 
$
(500
)
 
$
(500
)
Prepaid expenses and other current assets
$

 
$

 
$

 
$

 
$
(35
)
 
$
(44
)
Property and equipment, net
$

 
$

 
$

 
$

 
$
721

 
$
826

Other assets
$

 
$

 
$

 
$

 
$
(139
)
 
$
(175
)
Goodwill
$

 
$

 
$

 
$

 
$
4,121

 
$
4,121

Accrued expenses
$

 
$

 
$

 
$

 
$
785

 
$
883

Deferred revenue
$

 
$

 
$

 
$

 
$
(153
)
 
$
(153
)
Common stock
$

 
$

 
$

 
$

 
$
3,469

 
$
3,469

 
 
 
 
 
 
 
 
 
 
 
 
Significant Account and Transaction Review and Other:
 
 
 
 
 
 
 
 
 
 
 
Accounts receivables
$
(143
)
 
$
110

 
$
61

 
$
77

 
$
(8
)
 
$
127

Finance receivables, net
$

 
$

 
$

 
$

 
$
1,074

 
$
28

Inventory, net
$
(338
)
 
$
(348
)
 
$
(470
)
 
$
(305
)
 
$
(861
)
 
$
(1,067
)
Prepaid expenses and other current assets
$
13

 
$
13

 
$
13

 
$
(136
)
 
$
(150
)
 
$
(173
)
Other assets
$

 
$

 
$

 
$
(543
)
 
$
(600
)
 
$
(693
)
Property and equipment, net
$
2,865

 
$
2,561

 
$
2,168

 
$
(1,149
)
 
$
(737
)
 
$
(635
)
Accounts payable
$
17

 
$
19

 
$
21

 
$
25

 
$
27

 
$
29

Accrued expenses
$
4,506

 
$
5,222

 
$
6,166

 
$
8,319

 
$
9,087

 
$
9,877

Line of credit, net
$
13

 
$
13

 
$
13

 
$

 
$

 
$

Capital lease obligation and current obligations under long-term debt
$
4,117

 
$
3,566

 
$
2,998

 
$
(21
)
 
$
367

 
$
(5
)
Deferred revenue
$

 
$

 
$

 
$
(27
)
 
$
(27
)
 
$
(27
)
Deferred gain from sale-leaseback transactions
$
(685
)
 
$
(470
)
 
$
(255
)
 
$
(198
)
 
$
(198
)
 
$
(198
)
Deferred gain from sale-leaseback transactions, less current portion
$

 
$

 
$

 
$
(99
)
 
$
(49
)
 
$

Capital lease obligation and long-term debt, less current portion
$

 
$

 
$

 
$

 
$
697

 
$

Common stock
$

 
$

 
$

 
$
(166
)
 
$
(372
)
 
$
(867
)



The effect of the restatement on the previously filed consolidated balance sheet as of September 30, 2017 is as follows:
 
As of September 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
51,870

 
$

 
$
51,870

Accounts receivable
10,288

 
(473
)
 
9,815

Finance receivables, net
3,082

 
(1,641
)
 
1,441

Inventory, net
8,240

 
636

 
8,876

Prepaid expenses and other current assets
1,122

 
(66
)
 
1,056

Total current assets
74,602

 
(1,544
)
 
73,058

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
7,742

 

 
7,742

Other assets
750

 
(461
)
 
289

Property and equipment, net
11,850

 
(1,149
)
 
10,701

Deferred income taxes
28,205

 
(28,205
)
 

Intangibles, net
578

 

 
578

Goodwill
11,492

 

 
11,492

Total non-current assets
60,617

 
(29,815
)
 
30,802

 
 
 
 
 
 
Total assets
$
135,219

 
$
(31,359
)
 
$
103,860

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
14,211

 
$
295

 
$
14,506

Accrued expenses
3,795

 
8,422

 
12,217

Line of credit, net
7,051

 

 
7,051

Capital lease obligations and current obligations under long-term debt
2,649

 
(21
)
 
2,628

Income taxes payable
10

 
(10
)
 

Deferred revenue

 
439

 
439

Deferred gain from sale-leaseback transactions
197

 
(197
)
 

Total current liabilities
27,913

 
8,928

 
36,841

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income taxes

 
109

 
109

Capital lease obligations and long-term debt, less current portion
1,049

 

 
1,049

Accrued expenses, less current portion
62

 

 
62

Deferred gain from sale-leaseback transactions, less current portion
99

 
(99
)
 

Total long-term liabilities
1,210

 
10

 
1,220

 
 
 
 
 
 
Total liabilities
$
29,123

 
$
8,938

 
$
38,061

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 50,194,731 shares issued and outstanding at September 30, 2017
286,463

 
(167
)
 
286,296

Accumulated deficit
(183,505
)
 
(40,130
)
 
(223,635
)
Total shareholders’ equity
106,096

 
(43,435
)
 
62,661

Total liabilities, convertible preferred stock and shareholders’ equity
$
135,219

 
$
(31,359
)
 
$
103,860

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2017 is as follows:
 
Three months ended September 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Revenue:
 
 
 
 
 
License and transaction fees
$
19,944

 
$
(547
)
 
$
19,397

Equipment sales
5,673

 
189

 
5,862

Total revenue
25,617

 
(358
)
 
25,259

 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
Cost of services
13,326

 
(79
)
 
13,247

Cost of equipment
5,090

 
741

 
5,831

Total costs of sales
18,416

 
662

 
19,078

Gross profit
7,201

 
(1,020
)
 
6,181

 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
Selling, general and administrative
6,746

 
178

 
6,924

Integration and acquisition costs
762

 

 
762

Depreciation and amortization
245

 

 
245

Total operating expenses
7,753

 
178

 
7,931

Operating loss
(552
)
 
(1,198
)
 
(1,750
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest income
80

 

 
80

Interest expense
(209
)
 
(264
)
 
(473
)
Total other expense, net
(129
)
 
(264
)
 
(393
)
 
 
 
 
 
 
Loss before income taxes
(681
)
 
(1,462
)
 
(2,143
)
Benefit (provision) for income taxes
468

 
(496
)
 
(28
)
 
 
 
 
 
 
Net loss
(213
)
 
(1,958
)
 
(2,171
)
Preferred dividends
(334
)
 

 
(334
)
Net loss applicable to common shares
$
(547
)
 
$
(1,958
)
 
$
(2,505
)
Net loss per common share
 
 
 
 
 
Basic
$
(0.01
)
 
$
(0.04
)
 
$
(0.05
)
Diluted
$
(0.01
)
 
$
(0.04
)
 
$
(0.05
)
Weighted average number of common shares outstanding
 
 
 
 
 
Basic
47,573,364

 

 
47,573,364

Diluted
47,573,364

 

 
47,573,364

The effect of the restatement on the previously filed consolidated statement of cash flows for the three months ended September 30, 2017 is as follows:
 
Three months ended September 30, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(213
)
 
$
(1,958
)
 
$
(2,171
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
 
 
Non-cash stock-based compensation
576

 
(167
)
 
409

(Gain) loss on disposal of property and equipment
(18
)
 

 
(18
)
Non-cash interest and amortization of debt discount
15

 
2

 
17

Bad debt expense
118

 
50

 
168

Provision for inventory reserve

 
221

 
221

Depreciation and amortization
1,492

 
(122
)
 
1,370

Excess tax benefits
67

 

 
67

Deferred income taxes, net
(535
)
 
551

 
16

Recognition of deferred gain from sale-leaseback transactions
(43
)
 
43

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(3,192
)
 
43

 
(3,149
)
Finance receivables, net
8,771

 
397

 
9,168

Inventory, net
(3,648
)
 
(252
)
 
(3,900
)
Prepaid expenses and other current assets
(217
)
 
114

 
(103
)
Accounts payable and accrued expenses
(2,168
)
 
678

 
(1,490
)
Deferred revenue

 
171

 
171

Income taxes payable

 
(55
)
 
(55
)
Net cash provided by operating activities
1,005

 
(284
)
 
721

 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(992
)
 
272

 
(720
)
Proceeds from sale of property and equipment
45

 

 
45

Net cash used in investing activities
(947
)
 
272

 
(675
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Issuance of common stock in public offering, net
39,888

 

 
39,888

Repayment of capital lease obligations and long-term debt
(821
)
 
12

 
(809
)
Net cash provided by financing activities
39,067

 
12

 
39,079

 
 
 
 
 
 
Net increase in cash and cash equivalents
39,125

 

 
39,125

Cash and cash equivalents at beginning of year
12,745

 

 
12,745

Cash and cash equivalents at end of period
$
51,870

 
$

 
$
51,870

The effect of the restatement on the previously filed consolidated balance sheet as of December 31, 2017 is as follows:
 
As of December 31, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
15,386

 
$
(26
)
 
$
15,360

Accounts receivable
15,472

 
(765
)
 
14,707

Finance receivables, net
5,517

 
(2,221
)
 
3,296

Inventory, net
11,215

 
804

 
12,019

Prepaid expenses and other current assets
1,971

 
(361
)
 
1,610

Total current assets
49,561

 
(2,569
)
 
46,992

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
11,215

 
513

 
11,728

Other assets
1,120

 
(662
)
 
458

Property and equipment, net
12,622

 
(179
)
 
12,443

Deferred income taxes
14,774

 
(14,774
)
 

Intangibles, net
30,910

 

 
30,910

Goodwill
64,449

 
(46
)
 
64,403

Total non-current assets
135,090

 
(15,148
)
 
119,942

 
 
 
 
 
 
Total assets
$
184,651

 
$
(17,717
)
 
$
166,934

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
23,775

 
$
133

 
$
23,908

Accrued expenses
6,798

 
9,825

 
16,623

Capital lease obligations, current obligations under long-term debt, and collateralized borrowings
5,121

 
367

 
5,488

Income taxes payable
6

 
(6
)
 

Deferred revenue
595

 
135

 
730

Deferred gain from sale-leaseback transactions
198

 
(198
)
 

Total current liabilities
36,493

 
10,256

 
46,749

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Revolving credit facility
10,000

 

 
10,000

Deferred income taxes

 
91

 
91

Capital lease obligations, long-term debt, and collateralized borrowings, less current portion
23,874

 
696

 
24,570

Accrued expenses, less current portion
65

 

 
65

Deferred gain from sale-leaseback transactions, less current portion
49

 
(49
)
 

Total long-term liabilities
33,988

 
738

 
34,726

 
 
 
 
 
 
Total liabilities
$
70,481

 
$
10,994

 
$
81,475

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at December 31, 2017

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at December 31, 2017
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 53,619,898 shares issued and outstanding at December 31, 2017
307,053

 
3,097

 
310,150

Accumulated deficit
(196,021
)
 
(31,808
)
 
(227,829
)
Total shareholders’ equity
114,170

 
(31,849
)
 
82,321

Total liabilities, convertible preferred stock and shareholders’ equity
$
184,651

 
$
(17,717
)
 
$
166,934

The effect of the restatement on the previously filed consolidated statement of operations for the three and six months ended December 31, 2017 is as follows:
 
Three months ended December 31, 2017
 
Six months ended December 31, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
License and transaction fees
$
22,853

 
$
661

 
$
23,514

 
$
42,797

 
$
114

 
$
42,911

Equipment sales
9,653

 
(1,635
)
 
8,018

 
15,326

 
(1,446
)
 
13,880

Total revenue
32,506

 
(974
)
 
31,532

 
58,123

 
(1,332
)
 
56,791

 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
 
 
 
 
 
 
Cost of services
14,362

 
(6
)
 
14,356

 
27,688

 
(85
)
 
27,603

Cost of equipment
8,943

 
(939
)
 
8,004

 
14,033

 
(198
)
 
13,835

Total costs of sales
23,305

 
(945
)
 
22,360

 
41,721

 
(283
)
 
41,438

Gross profit
9,201

 
(29
)
 
9,172

 
16,402

 
(1,049
)
 
15,353

 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
8,329

 
676

 
9,005

 
15,075

 
854

 
15,929

Integration and acquisition costs
3,335

 

 
3,335

 
4,097

 

 
4,097

Depreciation and amortization
737

 

 
737

 
982

 

 
982

Total operating expenses
12,401

 
676

 
13,077

 
20,154

 
854

 
21,008

Operating loss
(3,200
)
 
(705
)
 
(3,905
)
 
(3,752
)
 
(1,903
)
 
(5,655
)
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest income
251

 
73

 
324

 
331

 
73

 
404

Interest expense
(494
)
 
(276
)
 
(770
)
 
(703
)
 
(540
)
 
(1,243
)
Total other expense, net
(243
)
 
(203
)
 
(446
)
 
(372
)
 
(467
)
 
(839
)
 
 
 
 
 
 
 
 
 
 
 
 
Loss before income taxes
(3,443
)
 
(908
)
 
(4,351
)
 
(4,124
)
 
(2,370
)
 
(6,494
)
(Provision) benefit for income taxes
(9,073
)
 
9,230

 
157

 
(8,605
)
 
8,734

 
129

 
 
 
 
 
 
 
 
 
 
 
 
Net loss
(12,516
)
 
8,322

 
(4,194
)
 
(12,729
)
 
6,364

 
(6,365
)
Preferred dividends

 

 

 
(334
)
 

 
(334
)
Net loss applicable to common shares
$
(12,516
)

$
8,322

 
$
(4,194
)
 
$
(13,063
)
 
$
6,364

 
$
(6,699
)
Net loss per common share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
(0.24
)
 
$
0.16

 
$
(0.08
)
 
$
(0.26
)
 
$
0.13

 
$
(0.13
)
Diluted
$
(0.24
)
 
$
0.16

 
$
(0.08
)
 
$
(0.26
)
 
$
0.13

 
$
(0.13
)
Weighted average number of common shares outstanding
 
 
 
 
 
 
 
 
 
 
 
Basic
52,150,106

 

 
52,150,106

 
49,861,735

 

 
49,861,735

Diluted
52,150,106

 

 
52,150,106

 
49,861,735

 

 
49,861,735

The effect of the restatement on the previously filed consolidated statement of cash flows for the six months ended December 31, 2017 is as follows:
 
Six months ended December 31, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(12,729
)
 
$
6,364

 
$
(6,365
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
 
 
Non-cash stock-based compensation
1,356

 
(372
)
 
984

(Gain) loss on disposal of property and equipment
(83
)
 
3

 
(80
)
Non-cash interest and amortization of debt discount
86

 
8

 
94

Bad debt expense
291

 
91

 
382

Provision for inventory reserve

 
1,091

 
1,091

Depreciation and amortization
3,476

 
(198
)
 
3,278

Excess tax benefits
67

 

 
67

Deferred income taxes, net
8,537

 
(8,696
)
 
(159
)
Recognition of deferred gain from sale-leaseback transactions
(93
)
 
93

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(5,290
)
 
(42
)
 
(5,332
)
Finance receivables, net
7,958

 
(626
)
 
7,332

Inventory, net
(5,822
)
 
(1,793
)
 
(7,615
)
Prepaid expenses and other current assets
(606
)
 
604

 
(2
)
Accounts payable and accrued expenses
6,950

 
754

 
7,704

Deferred revenue

 
570

 
570

Income taxes payable
40

 
(80
)
 
(40
)
Net cash provided by operating activities
4,138

 
(2,229
)
 
1,909

 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(1,767
)
 
33

 
(1,734
)
Proceeds from sale of property and equipment
157

 

 
157

Cash paid for acquisitions, net of cash acquired
(65,181
)
 

 
(65,181
)
Net cash used in investing activities
(66,791
)
 
33

 
(66,758
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Proceeds from collateralized borrowing from the transfer of finance receivables

 
1,075

 
1,075

Payment of debt issuance costs
(445
)
 

 
(445
)
Proceeds from issuance of long-term debt
25,100

 

 
25,100

Proceeds from revolving credit facility
10,000

 

 
10,000

Issuance of common stock in public offering, net
39,888

 

 
39,888

Repayment of line of credit
(7,111
)
 

 
(7,111
)
Repayment of capital lease obligations and long-term debt
(2,138
)
 
1,095

 
(1,043
)
Net cash provided by financing activities
65,294

 
2,170

 
67,464

 
 
 
 
 
 
Net increase in cash and cash equivalents
2,641

 
(26
)
 
2,615

Cash and cash equivalents at beginning of year
12,745

 

 
12,745

Cash and cash equivalents at end of period
$
15,386

 
$
(26
)
 
$
15,360

The effect of the restatement on the previously filed consolidated balance sheet as of March 31, 2018 is as follows:
 
As of March 31, 2018
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
17,107

 
$
(52
)
 
$
17,055

Accounts receivable
23,166

 
(3,723
)
 
19,443

Finance receivables, net
3,904

 
(1,670
)
 
2,234

Inventory, net
11,030

 
893

 
11,923

Prepaid expenses and other current assets
1,869

 
(591
)
 
1,278

Total current assets
57,076

 
(5,143
)
 
51,933

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
9,679

 
191

 
9,870

Other assets
1,214

 
(800
)
 
414

Property and equipment, net
12,198

 
45

 
12,243

Deferred income taxes
16,911

 
(16,911
)
 

Intangibles, net
30,119

 

 
30,119

Goodwill
64,196

 
(47
)
 
64,149

Total non-current assets
134,317

 
(17,522
)
 
116,795

 
 
 
 
 
 
Total assets
$
191,393

 
$
(22,665
)
 
$
168,728

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
29,446

 
$
128

 
$
29,574

Accrued expenses
7,961

 
10,547

 
18,508

Capital lease obligations and current obligations under long-term debt
4,475

 
(5
)
 
4,470

Deferred revenue
441

 
70

 
511

Deferred gain from sale-leaseback transactions
198

 
(198
)
 

Total current liabilities
42,521

 
10,542

 
53,063

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Revolving credit facility
10,000

 

 
10,000

Deferred income taxes

 
96

 
96

Capital lease obligations and long-term debt, less current portion
22,895

 

 
22,895

Accrued expenses, less current portion
66

 

 
66

Total long-term liabilities
32,961

 
96

 
33,057

 
 
 
 
 
 
Total liabilities
$
75,482

 
$
10,638

 
$
86,120

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,443 at March 31, 2018

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,443 at March 31, 2018
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 53,666,718 shares issued and outstanding at March 31, 2018
307,634

 
2,888

 
310,522

Accumulated deficit
(194,861
)
 
(36,191
)
 
(231,052
)
Total shareholders’ equity
115,911

 
(36,441
)
 
79,470

Total liabilities, convertible preferred stock and shareholders’ equity
$
191,393

 
$
(22,665
)
 
$
168,728

The effect of the restatement on the previously filed consolidated statement of operations for the three and nine months ended March 31, 2018 is as follows:
 
Three months ended March 31, 2018
 
Nine months ended March 31, 2018
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
License and transaction fees
$
27,020

 
$
(1,639
)
 
$
25,381

 
$
69,817

 
$
(1,525
)
 
$
68,292

Equipment sales
8,812

 
(601
)
 
8,211

 
24,138

 
(2,047
)
 
22,091

Total revenue
35,832

 
(2,240
)
 
33,592

 
93,955

 
(3,572
)
 
90,383

 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
 
 
 
 
 
 
Cost of services
16,012

 
25

 
16,037

 
43,700

 
(60
)
 
43,640

Cost of equipment
7,876

 
(166
)
 
7,710

 
21,909

 
(364
)
 
21,545

Total costs of sales
23,888

 
(141
)
 
23,747

 
65,609

 
(424
)
 
65,185

Gross profit
11,944

 
(2,099
)
 
9,845

 
28,346

 
(3,148
)
 
25,198

 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
9,572

 
57

 
9,629

 
24,647

 
911

 
25,558

Integration and acquisition costs
1,747

 
(70
)
 
1,677

 
5,844

 
(70
)
 
5,774

Depreciation and amortization
1,125

 
(20
)
 
1,105

 
2,107

 
(20
)
 
2,087

Total operating expenses
12,444

 
(33
)
 
12,411

 
32,598

 
821

 
33,419

Operating loss
(500
)
 
(2,066
)
 
(2,566
)
 
(4,252
)
 
(3,969
)
 
(8,221
)
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest income
134

 
92

 
226

 
465

 
165

 
630

Interest expense
(612
)
 
(251
)
 
(863
)
 
(1,315
)
 
(791
)
 
(2,106
)
Total other expense, net
(478
)
 
(159
)
 
(637
)
 
(850
)
 
(626
)
 
(1,476
)
 
 
 
 
 
 
 
 
 
 
 
 
Loss before income taxes
(978
)
 
(2,225
)
 
(3,203
)
 
(5,102
)
 
(4,595
)
 
(9,697
)
Benefit (provision) for income taxes
2,138

 
(2,158
)
 
(20
)
 
(6,467
)
 
6,576

 
109

 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
1,160

 
(4,383
)
 
(3,223
)
 
(11,569
)
 
1,981

 
(9,588
)
Preferred dividends
(334
)
 

 
(334
)
 
(668
)
 

 
(668
)
Net income (loss) applicable to common shares
$
826

 
$
(4,383
)
 
$
(3,557
)
 
$
(12,237
)
 
$
1,981

 
$
(10,256
)
Net income (loss) per common share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.02

 
$
(0.09
)
 
$
(0.07
)
 
$
(0.24
)
 
$
0.04

 
$
(0.20
)
Diluted
$
0.02

 
$
(0.09
)
 
$
(0.07
)
 
$
(0.24
)
 
$
0.04

 
$
(0.20
)
Weighted average number of common shares outstanding
 
 
 
 
 
 
 
 
 
 
 
Basic
53,637,085

 

 
53,637,085

 
51,101,813

 

 
51,101,813

Diluted
54,234,566

 
(597,481
)
 
53,637,085

 
51,101,813

 

 
51,101,813

The effect of the restatement on the previously filed consolidated statement of cash flows for the nine months ended March 31, 2018 is as follows:
 
Nine months ended March 31, 2018
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(11,569
)
 
$
1,981

 
$
(9,588
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
 
 
Non-cash stock-based compensation
2,005

 
(581
)
 
1,424

(Gain) loss on disposal of property and equipment
(112
)
 
13

 
(99
)
Non-cash interest and amortization of debt discount
100

 
18

 
118

Bad debt expense
506

 
4

 
510

Provision for inventory reserve

 
1,361

 
1,361

Depreciation and amortization
5,858

 
(272
)
 
5,586

Excess tax benefits
67

 

 
67

Deferred income taxes, net
6,400

 
(6,554
)
 
(154
)
Recognition of deferred gain from sale-leaseback transactions
(143
)
 
143

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(12,972
)
 
3,008

 
(9,964
)
Finance receivables, net
11,114

 
(2,912
)
 
8,202

Sale of finance receivables

 
2,051

 
2,051

Inventory, net
(5,624
)
 
(2,153
)
 
(7,777
)
Prepaid expenses and other current assets
(564
)
 
919

 
355

Accounts payable and accrued expenses
13,808

 
1,447

 
15,255

Deferred revenue
(185
)
 
536

 
351

Income taxes payable

 
(30
)
 
(30
)
Net cash provided by operating activities
8,689

 
(1,021
)
 
7,668

 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(3,005
)
 
(133
)
 
(3,138
)
Proceeds from sale of property and equipment
252

 

 
252

Cash paid for acquisitions, net of cash acquired
(65,181
)
 

 
(65,181
)
Net cash used in investing activities
(67,934
)
 
(133
)
 
(68,067
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Proceeds from collateralized borrowing from the transfer of finance receivables

 
1,075

 
1,075

Cash used in retirement of common stock
(156
)
 

 
(156
)
Proceeds from exercise of common stock options
109

 

 
109

Payment of debt issuance costs
(445
)
 

 
(445
)
Proceeds from issuance of long-term debt
25,100

 

 
25,100

Proceeds from revolving credit facility
12,500

 

 
12,500

Repayment of revolving credit facility
(2,500
)
 

 
(2,500
)
Issuance of common stock in public offering, net
39,888

 

 
39,888

Repayment of line of credit
(7,111
)
 

 
(7,111
)
Repayment of capital lease obligations and long-term debt
(3,778
)
 
27

 
(3,751
)
Net cash provided by financing activities
63,607

 
1,102

 
64,709

 
 
 
 
 
 
Net increase in cash and cash equivalents
4,362

 
(52
)
 
4,310

Cash and cash equivalents at beginning of year
12,745

 

 
12,745

Cash and cash equivalents at end of period
$
17,107

 
$
(52
)
 
$
17,055

The effect of the restatement on the previously filed consolidated balance sheet as of September 30, 2016 is as follows:
 
As of September 30, 2016
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
18,198

 
$

 
$
18,198

Accounts receivable
5,840

 
(233
)
 
5,607

Finance receivables, net
3,349

 

 
3,349

Inventory, net
4,264

 
(338
)
 
3,926

Prepaid expenses and other current assets
1,439

 
(87
)
 
1,352

Deferred income taxes
2,271

 
(2,271
)
 

Total current assets
35,361

 
(2,929
)
 
32,432

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
3,962

 

 
3,962

Other assets
163

 

 
163

Property and equipment, net
9,570

 
2,866

 
12,436

Deferred income taxes
25,568

 
(25,568
)
 

Intangibles, net
754

 

 
754

Goodwill
11,703

 

 
11,703

Total non-current assets
51,720

 
(22,702
)
 
29,018

 
 
 
 
 
 
Total assets
$
87,081

 
$
(25,631
)
 
$
61,450

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
8,693

 
$
17

 
$
8,710

Accrued expenses
3,912

 
4,223

 
8,135

Line of credit, net
7,258

 
13

 
7,271

Capital lease obligations and current obligations under long-term debt
834

 
4,118

 
4,952

Income taxes payable
8

 
7

 
15

Deferred revenue

 
94

 
94

Deferred gain from sale-leaseback transactions
685

 
(685
)
 

Total current liabilities
21,390

 
7,787

 
29,177

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income tax

 
47

 
47

Capital lease obligations and long-term debt, less current portion
1,517

 

 
1,517

Accrued expenses, less current portion
11

 

 
11

Total long-term liabilities
1,528

 
47

 
1,575

 
 
 
 
 
 
Total liabilities
$
22,918

 
$
7,834

 
$
30,752

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at September 30, 2016

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at September 30, 2016
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 40,295,425 shares issued and outstanding at September 30, 2016
244,996

 

 
244,996

Accumulated deficit
(183,971
)
 
(33,465
)
 
(217,436
)
Total shareholders’ equity
64,163

 
(36,603
)
 
27,560

Total liabilities, convertible preferred stock and shareholders’ equity
$
87,081

 
$
(25,631
)
 
$
61,450

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2016 is as follows:
 
Three months ended September 30, 2016
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Revenue:
 
 
 
 
 
License and transaction fees
$
16,365

 
$
(2
)
 
$
16,363

Equipment sales
5,223

 
(17
)
 
5,206

Total revenue
21,588

 
(19
)
 
21,569

 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
Cost of services
11,243

 
(144
)
 
11,099

Cost of equipment
4,178

 
(5
)
 
4,173

Total costs of sales
15,421

 
(149
)
 
15,272

Gross profit
6,167

 
130

 
6,297

 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
Selling, general and administrative
6,909

 
563

 
7,472

Depreciation and amortization
208

 

 
208

Total operating expenses
7,117

 
563

 
7,680

Operating loss
(950
)
 
(433
)
 
(1,383
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest income
73

 

 
73

Interest expense
(212
)
 
(335
)
 
(547
)
Change in fair value of warrant liabilities
(1,490
)
 

 
(1,490
)
Total other expense, net
(1,629
)
 
(335
)
 
(1,964
)
 
 
 
 
 
 
Loss before income taxes
(2,579
)
 
(768
)
 
(3,347
)
Benefit (provision) for income taxes
115

 
(138
)
 
(23
)
 
 
 
 
 
 
Net loss
(2,464
)
 
(906
)
 
(3,370
)
Preferred dividends
(334
)
 

 
(334
)
Net loss applicable to common shares
$
(2,798
)
 
$
(906
)
 
$
(3,704
)
Net loss per common share
 
 
 
 
 
Basic
$
(0.07
)
 
$
(0.03
)
 
$
(0.10
)
Diluted
$
(0.07
)
 
$
(0.03
)
 
$
(0.10
)
Weighted average number of common shares outstanding
 
 
 
 
 
Basic
38,488,005

 

 
38,488,005

Diluted
38,488,005

 

 
38,488,005

The effect of the restatement on the previously filed consolidated statement of cash flows for the three months ended September 30, 2016 is as follows:
 
Three months ended September 30, 2016
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(2,464
)
 
$
(906
)
 
$
(3,370
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
Non-cash stock-based compensation
211

 

 
211

Non-cash interest and amortization of debt discount
105

 
34

 
139

Bad debt expense
97

 
102

 
199

Provision for inventory reserve

 
248

 
248

Depreciation and amortization
1,301

 
302

 
1,603

Change in fair value of warrant liabilities
1,490

 

 
1,490

Deferred income taxes, net
(115
)
 
130

 
15

Recognition of deferred gain from sale-leaseback transactions
(215
)
 
215

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(1,038
)
 
35

 
(1,003
)
Finance receivables, net
(5
)
 

 
(5
)
Inventory, net
(2,223
)
 
(490
)
 
(2,713
)
Prepaid expenses and other current assets
(224
)
 
100

 
(124
)
Accounts payable and accrued expenses
(3,175
)
 
632

 
(2,543
)
Deferred revenue

 
(59
)
 
(59
)
Income taxes payable
(10
)
 
7

 
(3
)
Net cash used in operating activities
(6,265
)
 
350

 
(5,915
)
 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(810
)
 
187

 
(623
)
Net cash used in investing activities
(810
)
 
187

 
(623
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Cash used in retirement of common stock
(31
)
 

 
(31
)
Proceeds from exercise of common stock warrants
6,193

 

 
6,193

Repayment of capital lease obligations and long-term debt
(161
)
 
(537
)
 
(698
)
Net cash provided by financing activities
6,001

 
(537
)
 
5,464

 
 
 
 
 
 
Net decrease in cash and cash equivalents
(1,074
)
 

 
(1,074
)
Cash and cash equivalents at beginning of year
19,272

 

 
19,272

Cash and cash equivalents at end of period
$
18,198

 
$

 
$
18,198

The effect of the restatement on the previously filed consolidated balance sheet as of December 31, 2016 is as follows:
 
As of December 31, 2016
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
18,034

 
$

 
$
18,034

Accounts receivable
6,796

 
96

 
6,892

Finance receivables, net
1,442

 

 
1,442

Inventory, net
4,786

 
(348
)
 
4,438

Prepaid expenses and other current assets
1,764

 
(87
)
 
1,677

Deferred income taxes
2,271

 
(2,271
)
 

Total current assets
35,093

 
(2,610
)
 
32,483

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
3,956

 

 
3,956

Other assets
145

 
(1
)
 
144

Property and equipment, net
9,433

 
2,561

 
11,994

Deferred income taxes
25,568

 
(25,568
)
 

Intangibles, net
711

 

 
711

Goodwill
11,492

 

 
11,492

Total non-current assets
51,305

 
(23,008
)
 
28,297

 
 
 
 
 
 
Total assets
$
86,398

 
$
(25,618
)
 
$
60,780

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
9,090

 
$
19

 
$
9,109

Accrued expenses
2,912

 
4,629

 
7,541

Line of credit, net
7,078

 
13

 
7,091

Capital lease obligations and current obligations under long-term debt
766

 
3,565

 
4,331

Income taxes payable
6

 
15

 
21

Deferred revenue

 
478

 
478

Deferred gain from sale-leaseback transactions
470

 
(470
)
 

Total current liabilities
20,322

 
8,249

 
28,571

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income taxes

 
63

 
63

Capital lease obligations and long-term debt, less current portion
1,394

 

 
1,394

Accrued expenses, less current portion
52

 

 
52

Total long-term liabilities
1,446

 
63

 
1,509

 
 
 
 
 
 
Total liabilities
$
21,768

 
$
8,312

 
$
30,080

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at December 31, 2016

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at December 31, 2016
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 40,321,941 shares issued and outstanding at December 31, 2016
245,230

 

 
245,230

Accumulated deficit
(183,738
)
 
(33,930
)
 
(217,668
)
Total shareholders’ equity
64,630

 
(37,068
)
 
27,562

Total liabilities, convertible preferred stock and shareholders’ equity
$
86,398

 
$
(25,618
)
 
$
60,780

The effect of the restatement on the previously filed consolidated statement of operations for the three and six months ended December 31, 2016 is as follows:
 
Three months ended December 31, 2016
 
Six months ended December 31, 2016
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
License and transaction fees
$
16,639

 
$
(2
)
 
$
16,637

 
$
33,004

 
$
(4
)
 
$
33,000

Equipment sales
5,117

 
33

 
5,150

 
10,340

 
16

 
10,356

Total revenue
21,756

 
31

 
21,787

 
43,344

 
12

 
43,356

 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
 
 
 
 
 
 
Cost of services
11,389

 
(143
)
 
11,246

 
22,632

 
(287
)
 
22,345

Cost of equipment
4,033

 
63

 
4,096

 
8,211

 
58

 
8,269

Total costs of sales
15,422

 
(80
)
 
15,342

 
30,843

 
(229
)
 
30,614

Gross profit
6,334

 
111

 
6,445

 
12,501

 
241

 
12,742

 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
5,793

 
236

 
6,029

 
12,702

 
799

 
13,501

Depreciation and amortization
307

 

 
307

 
515

 

 
515

Total operating expenses
6,100

 
236

 
6,336

 
13,217

 
799

 
14,016

Operating income (loss)
234

 
(125
)
 
109

 
(716
)
 
(558
)
 
(1,274
)
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest income
200

 

 
200

 
273

 

 
273

Interest expense
(201
)
 
(317
)
 
(518
)
 
(413
)
 
(652
)
 
(1,065
)
Change in fair value of warrant liabilities

 

 

 
(1,490
)
 

 
(1,490
)
Total other expense, net
(1
)
 
(317
)
 
(318
)
 
(1,630
)
 
(652
)
 
(2,282
)
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
233

 
(442
)
 
(209
)
 
(2,346
)
 
(1,210
)
 
(3,556
)
(Provision) benefit for income taxes

 
(23
)
 
(23
)
 
115

 
(161
)
 
(46
)
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
233

 
(465
)
 
(232
)
 
(2,231
)
 
(1,371
)
 
(3,602
)
Preferred dividends

 

 

 
(334
)
 

 
(334
)
Net income (loss) applicable to common shares
$
233

 
$
(465
)
 
$
(232
)
 
$
(2,565
)
 
$
(1,371
)
 
$
(3,936
)
Net income (loss) per common share
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.01

 
$
(0.02
)
 
$
(0.01
)
 
$
(0.07
)
 
$
(0.03
)
 
$
(0.10
)
Diluted
$
0.01

 
$
(0.02
)
 
$
(0.01
)
 
$
(0.07
)
 
$
(0.03
)
 
$
(0.10
)
Weighted average number of common shares outstanding
 
 
 
 
 
 
 
 
 
 
 
Basic
40,308,934

 

 
40,308,934

 
39,398,469

 

 
39,398,469

Diluted
40,730,712

 
(421,778
)
 
40,308,934

 
39,398,469

 

 
39,398,469

The effect of the restatement on the previously filed consolidated statement of cash flows for the six months ended December 31, 2016 is as follows:
 
Six months ended December 31, 2016
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(2,231
)
 
$
(1,371
)
 
$
(3,602
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
Non-cash stock-based compensation
445

 

 
445

(Gain) loss on disposal of property and equipment
(31
)
 
(3
)
 
(34
)
Non-cash interest and amortization of debt discount
26

 
39

 
65

Bad debt expense
450

 
(119
)
 
331

Provision for inventory reserve

 
480

 
480

Depreciation and amortization
2,564

 
600

 
3,164

Change in fair value of warrant liabilities
1,490

 

 
1,490

Deferred income taxes, net
(115
)
 
145

 
30

Recognition of deferred gain from sale-leaseback transactions
(430
)
 
430

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(2,347
)
 
(71
)
 
(2,418
)
Finance receivables, net
2,119

 

 
2,119

Inventory, net
(2,689
)
 
(714
)
 
(3,403
)
Prepaid expenses and other current assets
(542
)
 
100

 
(442
)
Accounts payable and accrued expenses
(3,840
)
 
1,140

 
(2,700
)
Deferred revenue

 
326

 
326

Income taxes payable
(12
)
 
15

 
3

Net cash used in operating activities
(5,143
)
 
997

 
(4,146
)
 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(1,944
)
 
192

 
(1,752
)
Proceeds from sale of property and equipment
61

 

 
61

Net cash used in investing activities
(1,883
)
 
192

 
(1,691
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Cash used in retirement of common stock
(31
)
 

 
(31
)
Proceeds from exercise of common stock warrants
6,193

 

 
6,193

Repayment of line of credit

 
(106
)
 
(106
)
Repayment of capital lease obligations and long-term debt
(374
)
 
(1,083
)
 
(1,457
)
Net cash provided by financing activities
5,788

 
(1,189
)
 
4,599

 
 
 
 
 
 
Net decrease in cash and cash equivalents
(1,238
)
 

 
(1,238
)
Cash and cash equivalents at beginning of year
19,272

 

 
19,272

Cash and cash equivalents at end of period
$
18,034

 
$

 
$
18,034

The effect of the restatement on the previously filed consolidated balance sheet as of March 31, 2017 is as follows:
 
As of March 31, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
17,780

 
$

 
$
17,780

Accounts receivable
6,734

 
(72
)
 
6,662

Finance receivables, net
2,057

 
92

 
2,149

Inventory, net
4,147

 
(470
)
 
3,677

Prepaid expenses and other current assets
1,628

 
(34
)
 
1,594

Deferred income taxes
2,271

 
(2,271
)
 

Total current assets
34,617

 
(2,755
)
 
31,862

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
7,548

 

 
7,548

Other assets
137

 
94

 
231

Property and equipment, net
9,173

 
2,168

 
11,341

Deferred income taxes
25,359

 
(25,359
)
 

Intangibles, net
666

 

 
666

Goodwill
11,492

 

 
11,492

Total non-current assets
54,375

 
(23,097
)
 
31,278

 
 
 
 
 
 
Total assets
$
88,992

 
$
(25,852
)
 
$
63,140

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
11,529

 
$
290

 
$
11,819

Accrued expenses
3,111

 
5,681

 
8,792

Line of credit, net
7,021

 
13

 
7,034

Capital lease obligations and current obligations under long-term debt
786

 
2,999

 
3,785

Income taxes payable

 
23

 
23

Deferred revenue

 
310

 
310

Deferred gain from sale-leaseback transactions
255

 
(255
)
 

Total current liabilities
22,702

 
9,061

 
31,763

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income taxes

 
78

 
78

Capital lease obligations and long-term debt, less current portion
1,239

 

 
1,239

Accrued expenses, less current portion
52

 

 
52

Total long-term liabilities
1,291

 
78

 
1,369

 
 
 
 
 
 
Total liabilities
$
23,993

 
$
9,139

 
$
33,132

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,775 at March 31, 2017

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,775 at March 31, 2017
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 40,327,675 shares issued and outstanding at March 31, 2017
245,463

 

 
245,463

Accumulated deficit
(183,602
)
 
(34,991
)
 
(218,593
)
Total shareholders’ equity
64,999

 
(38,129
)
 
26,870

Total liabilities, convertible preferred stock and shareholders’ equity
$
88,992

 
$
(25,852
)
 
$
63,140

The effect of the restatement on the previously filed consolidated statement of operations for the three and nine months ended March 31, 2017 is as follows:
 
Three months ended March 31, 2017
 
Nine months ended March 31, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
License and transaction fees
$
17,459

 
$
(1
)
 
$
17,458

 
$
50,463

 
$
(5
)
 
$
50,458

Equipment sales
9,001

 
(158
)
 
8,843

 
19,341

 
(142
)
 
19,199

Total revenue
26,460

 
(159
)
 
26,301

 
69,804

 
(147
)
 
69,657

 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
 
 
 
 
 
 
Cost of services
11,876

 
(143
)
 
11,733

 
34,508

 
(430
)
 
34,078

Cost of equipment
7,959

 
267

 
8,226

 
16,170

 
325

 
16,495

Total costs of sales
19,835

 
124

 
19,959

 
50,678

 
(105
)
 
50,573

Gross profit
6,625

 
(283
)
 
6,342

 
19,126

 
(42
)
 
19,084

 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
5,947

 
595

 
6,542

 
18,649

 
1,394

 
20,043

Depreciation and amortization
259

 

 
259

 
774

 

 
774

Total operating expenses
6,206

 
595

 
6,801

 
19,423

 
1,394

 
20,817

Operating income (loss)
419

 
(878
)
 
(459
)
 
(297
)
 
(1,436
)
 
(1,733
)
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest income
114

 

 
114

 
387

 

 
387

Interest expense
(188
)
 
(369
)
 
(557
)
 
(601
)
 
(1,021
)
 
(1,622
)
Change in fair value of warrant liabilities

 

 

 
(1,490
)
 

 
(1,490
)
Total other expense, net
(74
)
 
(369
)
 
(443
)
 
(1,704
)
 
(1,021
)
 
(2,725
)
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
345

 
(1,247
)
 
(902
)
 
(2,001
)
 
(2,457
)
 
(4,458
)
(Provision) benefit for income taxes
(209
)
 
186

 
(23
)
 
(94
)
 
25

 
(69
)
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
136

 
(1,061
)
 
(925
)
 
(2,095
)
 
(2,432
)
 
(4,527
)
Preferred dividends
(334
)
 

 
(334
)
 
(668
)
 

 
(668
)
Net loss applicable to common shares
$
(198
)
 
$
(1,061
)
 
$
(1,259
)
 
$
(2,763
)
 
$
(2,432
)
 
$
(5,195
)
Net loss per common share
 
 
 
 
 
 
 
 
 
 
 
Basic
$

 
$
(0.03
)
 
$
(0.03
)
 
$
(0.07
)
 
$
(0.06
)
 
$
(0.13
)
Diluted
$

 
$
(0.03
)
 
$
(0.03
)
 
$
(0.07
)
 
$
(0.06
)
 
$
(0.13
)
Weighted average number of common shares outstanding
 
 
 
 
 
 
 
 
 
 
 
Basic
40,327,697

 

 
40,327,697

 
39,703,690

 

 
39,703,690

Diluted
40,327,697

 

 
40,327,697

 
39,703,690

 

 
39,703,690

The effect of the restatement on the previously filed consolidated statement of cash flows for the nine months ended March 31, 2017 is as follows:
 
Nine months ended March 31, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(2,095
)
 
$
(2,432
)
 
$
(4,527
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
Non-cash stock-based compensation
678

 

 
678

(Gain) loss on disposal of property and equipment
(59
)
 

 
(59
)
Non-cash interest and amortization of debt discount
98

 

 
98

Bad debt expense
577

 
(117
)
 
460

Provision for inventory reserve

 
804

 
804

Depreciation and amortization
3,774

 
905

 
4,679

Change in fair value of warrant liabilities
1,490

 

 
1,490

Deferred income taxes, net
94

 
(48
)
 
46

Recognition of deferred gain from sale-leaseback transactions
(646
)
 
646

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(2,388
)
 
72

 
(2,316
)
Finance receivables, net
(2,113
)
 
(67
)
 
(2,180
)
Inventory, net
(2,042
)
 
(915
)
 
(2,957
)
Prepaid expenses and other current assets
(406
)
 
(48
)
 
(454
)
Accounts payable and accrued expenses
(1,239
)
 
2,501

 
1,262

Deferred revenue

 
157

 
157

Income taxes payable
(18
)
 
22

 
4

Net cash used in operating activities
(4,295
)
 
1,480

 
(2,815
)
 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(2,818
)
 
282

 
(2,536
)
Proceeds from sale of property and equipment
105

 

 
105

Net cash used in investing activities
(2,713
)
 
282

 
(2,431
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Cash used in retirement of common stock
(31
)
 

 
(31
)
Proceeds from exercise of common stock warrants
6,193

 

 
6,193

Payment of debt issuance costs
(90
)
 

 
(90
)
Repayment of line of credit

 
(106
)
 
(106
)
Repayment of capital lease obligations and long-term debt
(556
)
 
(1,656
)
 
(2,212
)
Net cash provided by financing activities
5,516

 
(1,762
)
 
3,754

 
 
 
 
 
 
Net decrease in cash and cash equivalents
(1,492
)
 

 
(1,492
)
Cash and cash equivalents at beginning of year
19,272

 

 
19,272

Cash and cash equivalents at end of period
$
17,780

 
$

 
$
17,780

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended June 30, 2017 is as follows:
 
Three months ended June 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Revenue:
 
 
 
 
 
License and transaction fees
$
18,679

 
$
(3
)
 
$
18,676

Equipment sales
15,610

 
(2,507
)
 
13,103

Total revenue
34,289

 
(2,510
)
 
31,779

 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
Cost of services
12,545

 
(103
)
 
12,442

Cost of equipment
14,224

 
(864
)
 
13,360

Total costs of sales
26,769

 
(967
)
 
25,802

Gross profit
7,520

 
(1,543
)
 
5,977

 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
Selling, general and administrative
6,844

 
1,290

 
8,134

Depreciation and amortization
244

 

 
244

Total operating expenses
7,088

 
1,290

 
8,378

Operating income (loss)
432

 
(2,833
)
 
(2,401
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest income
95

 

 
95

Interest expense
(291
)
 
(315
)
 
(606
)
Total other expense, net
(196
)
 
(315
)
 
(511
)
 
 
 
 
 
 
Income (loss) before income taxes
236

 
(3,148
)
 
(2,912
)
Benefit (provision) for income taxes
7

 
(33
)
 
(26
)
 
 
 
 
 
 
Net income (loss)
243

 
(3,181
)
 
(2,938
)
Preferred dividends

 

 

Net income (loss) applicable to common shares
$
243

 
$
(3,181
)
 
$
(2,938
)
Net income (loss) per common share
 
 
 
 
 
Basic
$
0.01

 
$
(0.08
)
 
$
(0.07
)
Diluted
$
0.01

 
$
(0.08
)
 
$
(0.07
)
Weighted average number of common shares outstanding
 
 
 
 
 
Basic
40,331,993

 

 
40,331,993

Diluted
40,772,482

 
(440,489
)
 
40,331,993